Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Song, J.S.
Right arrow Articles by Grzesik, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, J.S.
Right arrow Articles by Grzesik, W.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Biological

Targeting and Immobilization of Bioactive Peptides on Dentin Matrix

J.S. Song1,2, A. Wlodarska2, H.J. Ko2,3 and W.J. Grzesik2,*

1 Department of Endodontics and
2 Department of Anatomy and Cell Biology, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Levy Bldg, Rm 423, Philadelphia, PA 19104, USA; and
3 Department of Conservative Dentistry, University of Ulsan, Asan Medical Center, Seoul, Korea

Correspondence: * corresponding author, yumigimai{at}comcast.net, jscsong{at}yahoo.com


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The regeneration of structurally/functionally competent tooth root cementum is a critical step for the successful restoration of periodontal attachment. In this study, we tested whether a poly-glutamic acid-rich domain and glutamine-containing transglutaminase substrate can be used to target biologically active peptides to the mineralized root matrix and to bind such peptides covalently to the organic matrix. As a biologically active model molecule, the integrin-binding motif, RGD, was used. The effects of immobilization of such synthetic peptides to the dentin matrix on cementoblastic adhesion in vitro and cementogenesis in vivo were studied. In vitro, cementoblastic adhesion improved significantly when the dentin surface contained covalently bound peptides. In vivo, this bound peptide significantly increased cementum formation compared with that attained in control conditions. Transglutaminase-catalyzed covalent binding of bioactive peptides targeted to mineralized collagenous dentin matrix via the poly-glutamate domain can be readily achieved. This approach offers potential for clinical use in periodontal regeneration.

Key Words: peptide • dentin • bioactive • periodontal • regeneration


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The regeneration of cementum on previously exposed root surfaces is an important step in periodontal regeneration (Grzesik and Narayanan,2002). It is apparent that targeted delivery/sequestration of bioactive substances onto the tooth root surface should enhance this process. Furthermore, for such substances to influence cementogenesis, a relatively late stage in the healing process, it is imperative that they remain bound to the root for a considerably long time.

Bone sialoprotein (BSP), a major non-collagenous protein found in cementum matrix, is believed to bind hydroxyapatite via several domains of 8 contiguous glutamic acid residues (Somerman et al., 1990; MacNeil et al., 1995; Fujisawa et al., 1996; Saygin et al., 2000).

Transglutaminases (TGase) are enzymes that catalyze the rapid generation of covalent crosslinks between proteins during important biological processes, producing a supramolecular structure with extra rigidity and resistance against proteolytic degradation (Lorand and Graham, 2003). Transglutaminases crosslink with proteins through an acyl-transfer reaction between the carboxamide group of peptide-bound glutamine residue (acyl donor) and the amino group of peptide-bound lysine residue (acceptor), resulting in a {varepsilon}({gamma}-glutamyl) lysine isopeptide bond (Folk and Finlayson, 1977).

We hypothesized that peptides containing a poly-glutamic acid domain can be utilized to target bioactive molecules to mineralized tooth matrix. Also, by including the transglutaminase substrate domain, glutamine residues, within the peptide and simultaneously supplying exogenous transglutaminase, we could theoretically achieve a stable binding of the peptide to collagen exposed on the tooth root surface. Thus, such a system should, in principle, enhance the regenerative process.

For technical reasons (i.e., the stability and the relative ease of observing the biological effects), and based on the current knowledge of the critical role of integrins for mesenchymal cell survival, proliferation, and differentiation, we chose the integrin-binding RGD motif as a model of a bioactive molecule for this study. In addition, several RGD-containing proteins (BSP, cementum attachment protein, and collagen) are present in native cementum (Hynes, 1992; Ganss et al., 1999; Ivanovski et al., 1999; Nanci, 2003), suggesting that they may have anabolic effects on cemento and osteoprecursors via integrin-mediated/modulated pathways (Nakae et al., 1991; MacNeil and Somerman, 1993, 1999; Narayanan and Bartold, 1996). Therefore, it was reasonable to hypothesize that the interaction of committed cementoblastic cells with immobilized integrin ligand would result in increased cell adhesion in vitro, which, very likely, would enhance cementogenesis in vivo.


    MATERIALS & METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
All the relevant protocols were approved by the appropriate institutional committees (IRB, Institutional Animal Care Committee [IACUC]) at the University of Pennsylvania. Informed consent was obtained for the use of human tissues.

Cell Culture
Normal human-cementum-derived cell (HCDC) cultures were established as previously described (Grzesik et al., 1998) (see APPENDIX).

Dentin Substrates
Human root dentin obtained from the middle third of the root was dissected and pulverized under liquid N2 with a Spex Freezer Mill (SPEX CertiPrep, Metuchen, NJ, USA), and tissue fragments ranging in size from 500 to 750 microns were obtained via appropriate sieves. Following extensive washing with phosphate-buffered solution (PBS), dentin powder was digested with collagenase P (200 mU/mL in PBS containing 2 mM CaCl2) for 2 hrs, for removal of all remaining soft tissue.

Tooth root dentin slices, 1 mm thick, were prepared with the use of a circular diamond saw (Buehler, Lake Bluff, IL, USA). Four or 8 small chambers, 1 mm wide and 0.5 mm deep, were prepared on each slice by means of a round carbide bur (#7002, Dentsply, York, PA, USA).

All dentin substrates used were rehydrated in PBS for 30 min before use.

Peptides
Peptides (Sigma-Genosys, The Woodlands, TX, USA) were designed to contain 3 functional domains: (1) a mineral-binding domain consisting of polyglutamic acid residues, EEEEEEEE; (2) a transglutaminase substrate domain consisting of glutamine residues, QEQ; and (3) an integrin-binding domain, RGD, with or without biotin. Peptides lacking in any of these 3 functional domains were also synthesized (for more details, see TableGo).


View this table:
[in this window]
[in a new window]

 
Table. Description of the Synthetic Peptides* and Their Corresponding Amino Acid Sequences
 
The peptide and transglutaminase (Sigma, St. Louis, MO, USA) mix was prepared ex tempore for all of the following experiments, when applicable.

Evaluation of Targeting and Immobilization of Peptides
Dentin slices with drilled chambers were treated with 3% hydrogen peroxide for 10 min and then washed extensively with water and PBS. For a single chamber, 1.0 µL of either the mixture of 0.2 mg/mL of biotinylated peptide and 0.065 unit/mL solution of transglutaminase or peptide alone or transglutaminase alone or PBS alone was applied for 2 hrs. Bound peptide was visualized with streptavidin-horseradish peroxidase conjugate and DAB substrate (Zymed Laboratories Inc., San Francisco, CA, USA). The intensity of DAB staining within each chamber was measured and evaluated with the use of NIH Image software (Scion image, version 1.62) (see APPENDIX).

Cell Attachment Assays
Dentin slices containing small chambers were placed into the wells of 48-well culture plates. A 250-µL quantity of either the mixture of 0.2 mg/mL of fully functional peptide and 0.065 unit/mL transglutaminase or transglutaminase alone or PBS alone was added to each well, and the dentin slice was left completely immersed in the solution for 2 hrs. Following the crosslinking of peptides to dentin matrix, samples were washed extensively. Trypsin-released cementoblastic (HCDC) cells were suspended in serum-free {alpha}-MEM medium (SFM) at a density of 1 x 105/mL. A 1-µL quantity of medium containing the cells was then added to each dentin chamber. Dentin slices were then incubated at 37°C for 24 hrs, washed with PBS, fixed in 4% formaldehyde, and then stained with0.25% Coomassie Brilliant Blue R-250 (Bio-Rad, Hercules, CA, USA) so that attached cells could be visualized. Images of cell attachment to the dentin substrates were captured with an inverted microscope (Nikon Diaphot 300) equipped with a Nikon Digital Still Camera DXM 1200 (Nikon Instrument Inc., Melville, NY, USA) and connected to an IBM-compatible PC computer equipped with Nikon ACT-1 Software (Nikon Instrument Inc.).

In another set of experiments, transglutaminase and either fully functional peptide, TG-null peptide, or MB-null peptide were applied to root dentin slices. The stained cells within the chamber were counted with an inverted microscope (100x magnification), and the obtained data were subjected to statistical analysis by ANOVA.

In vivo Cementogenesis Assay
Biotinylated fully functional peptide, fully functional peptide, TG-null peptide, MB-null peptide, or RGD-null peptide (0.4 mg/mL) was mixed with 0.065 unit/mL of transglutaminase. For controls, biotinylated fully functional peptide alone, transglutaminase alone, and PBS alone were prepared. Dentin powder (50 mg) was treated with 65 µL of prepared solutions for 90 min. Following this step, the dentin powder was prepared for transplantation into immunodeficient mice as previously described (Grzesik et al., 1998) (see APPENDIX). In one separate experiment, prepared transplants were used for the evaluation of cell loading. After 8 wks, the transplants were recovered and processed for routine histological examination, hematoxylineosin [HE] staining. Microscopic images (magnification, 250x) were captured as described above. For each section analyzed (50/group), the total section area (T) and the area occupied by the dentin powder vehicle (Vc), as well as the area occupied by the newly formed cementum matrix (CMtx), were measured. The percentage of the CMtx against (T-Vc) was calculated for all samples, as the measure of cementum formation.


Formula

The data were analyzed by non-paired Student’s t test. At least 3 different transplants/group were analyzed.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Evaluation of Targeting and Immobilization of Peptides
The results from the evaluation of poly-glutamate-mediated targeting and transglutaminase-catalyzed crosslinking of biotinylated synthetic peptide to mineralized tissue are shown in Fig. 1Go. The greatest intensity of staining was observed within the dentin chambers that were treated with both the peptide and transglutaminase, followed by those treated with peptide alone and transglutaminase alone. These results indicate that transglutaminase-mediated crosslinking of peptides (peptide and transglutaminase group) resulted in significantly higher (about three-fold) retention of synthetic peptide compared with the peptide bound via the poly-glutamate alone (peptide alone group) (Fig. 1Go).


Figure 1
View larger version (24K):
[in this window]
[in a new window]

 
Figure 1. Poly-glutamate targeting and transglutaminase–crosslinking result in stable retention of synthetic peptide to mineralized dentin matrix. (A) Streptavidin-HRP-DAB staining reaction within the dentin chambers pre-treated with test solutions. Note the intense staining within the chamber that was pre-treated with biotinylated fully functional peptide [*(Btn)-TG-MB-RGD] and transglutaminase, lesser staining within the chamber that was pre-treated with peptide [*(Btn)-TG-MB-RGD] alone, transglutaminase alone, or the background PBS (control) groups. (B) The average pixel density of the staining in the dentin chambers was measured and shown as the difference between the experimental groups and the PBS group (control).

 
Cell Attachment Assays
Significantly greater numbers of HCDC were attached to the dentin matrix surfaces that were treated with the fully functional peptide (TG-MB-RGD) and transglutaminase compared with the dentin surfaces that were treated with transglutaminase alone or PBS alone. Also, attached cells spread better on dentin matrix surfaces treated with the fully functional peptide in the presence of transglutaminase than in other conditions (Fig. 2aGo), indicating that the transglutaminase-catalyzed crosslinking of peptides to mineralized human dentin matrix promoted enhanced cell adhesion.


Figure 2A
View larger version (71K):
[in this window]
[in a new window]

 
Figure 2a. Attachment of HCDC to dentin in vitro. Cell attachment to the dentin matrix (Coomassie blue staining). (A) Poly-glutamate targeting and transglutaminase-crosslinking of the peptide (TG-MB-RGD and transglutaminase) to mineralized dentin matrix results in a significant increase in cell attachment compared with that to the dentin surfaces that were treated with (B) transglutaminase alone and (C) PBS alone. The cells also spread better on the surfaces pre-treated with both the fully functional peptide and transglutaminase compared with the other groups. Original magnifications at 100x and 200x (inset). Scale bar represents 20 µm.

 
Further, when quantifying the cell adhesion as a function of peptide composition, we found that the highest number of cells was attached to the dentin matrix surface that was treated with the fully functional peptide (P < 0.05 compared with control), followed by the TG-null peptide and MB-null peptide (although the latter tendency did not reach statistical significance) (Fig. 2bGo). There was no significant difference in cell attachment between the modified peptides and transglutaminase groups when applied alone and the PBS alone group (not shown). These results show that, to achieve maximum biological effect, all of the active components (i.e., both TG and MB domains) in the synthetic peptide are required for efficient binding to the dentin matrix.


Figure 2B
View larger version (16K):
[in this window]
[in a new window]

 
Figure 2b. Quantitative analysis of HCDC cell attachment to dentin. *Statistically significant (by ANOVA). In the presence of transglutaminase, the highest number of cells was attached to the dentin matrix surface that was pre-treated with the fully functional peptide (TG-MB-RGD), followed by the TG-null peptide and the MB-null peptide, indicating that both of the active domains (i.e., both TG and MB domains) in a synthetic peptide are required for peptide retention and the greatest biological effect.

 
In vivo Cementogenesis Assay
We evaluated the efficiency of cell loading of transplants by extracting and measuring DNA content from cells within prepared transplants. We found that the loading procedure was highly efficient, and that 96% of the initially applied cells were retained in the transplants at the end of the procedure. Further, the modifications of the vehicles (or the type of vehicle) had no effect on the number of cells retained.

In vivo, the newly formed cementum was tightly bound to the dentin matrix substrates pre-treated with fully functional peptide and transglutaminase (Fig. 3aGo, groups D, E). Also, these groups showed a statistically significant (p < 0.05) increase in new cementum formation when compared with all the other groups (Fig. 3bGo). In contrast, unmodified dentin or dentin treated with mutated functional peptide (Fig. 3aGo, groups A, F, H) showed some separation between the dentin matrix substrates and the newly formed cementum, indicating that bound functional peptide was critical for the creation of a tight dentin-cementum interface. In these experiments, dentin was treated with either mutated functional peptides (groups F, H), peptide alone (group B), or transglutaminase alone (group C). Dentin treated in any of these ways did not result in significant changes in the volume of cementum formed in transplants when compared with control (group A) (Fig. 3bGo). In particular, the dentin matrix substrate treated with a mutated mineral-binding domain (group G) showed significantly less cementum formation when compared with control (group A). These in vivo results are consistent with the in vitro data and indicate that the increased enhancement of cell adhesion to the dentin matrix substrate caused by covalently bound peptides enhanced cementum formation in vivo.


Figure 3A
View larger version (103K):
[in this window]
[in a new window]

 
Figure 3a. Cementogenesis in vivo. Morphology of transplants showing newly formed cementum matrix (CMtx) deposition against the dentin vehicle (Vc). Original magnification, 250x. Dentin powder was pre-treated with (A) PBS, (B) *(Btn)-TG-MB-RGD peptide, (C) transglutaminase (TGase), (D) *(Btn)-TG-MB-RGD peptide and transglutaminase, (E) TG-MB-RGD peptide and transglutaminase, (F) TG-null peptide and transglutaminase, (G) MB-null peptide and transglutaminase, and (H) RGD-null peptide and transglutaminase. Sequestering the peptides via the mineral-binding domain on the surface of mineralized matrix, followed by the transglutaminase-catalyzed immobilization of such peptides to the organic part of root matrix via the transglutaminase substrate sequence, increased cementum formation in vivo (D,E). Also note that the newly formed cementum matrix abuts dentin vehicle, creating a tight dentin-cementum interface that does not separate, especially evident when dentin powder was pre-treated with fully functional peptides (TG-MB-RGD) and transglutaminase (D,E), indicating that a stable binding of the peptide is critical for creating a tight dentin-cementum interface. White arrows indicate the "splitting" of newly formed cementum from the vehicle (A,F,H).

 

Figure 3B
View larger version (26K):
[in this window]
[in a new window]

 
Figure 3b. Morphometric analysis of the in vivo cementogenesis on modified dentin substrate. Note the significant increase in the cementum formation on the dentin surface that was treated with biotinylated fully functional peptide [*(Btn)-TG-MB-RGD] or fully functional peptide (TG-MB-RGD) and transglutaminase (D,E). *Statistically significant (by non-paired Student’s t test).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Bioactive molecules such as growth factors, extracellular matrix components, and cytokines are involved in cementogenesis (Nakae et al., 1991; MacNeil and Somerman, 1993, 1999; Pitaru et al., 1994; Narayanan and Bartold, 1996). In this study, we developed a new strategy to target and stably incorporate bioactive molecules into the mineralized matrix of the tooth root. This strategy is based upon the binding of poly-glutamic acid residues to the surface of mineralized matrix, followed by the transglutaminase-catalyzed immobilization of these peptides to the organic part of the root matrix. The effectiveness of this strategy was confirmed in vitro. Using this approach, we have demonstrated a significant increase in the amount of peptide bound to dentin matrix. In addition, when the RGD cell-binding motif was included, a significant increase in cementoblastic cell attachment was evident in vitro compared with that in controls. Last, the combination of these bioactive treatments enhanced cementogenesis in vivo, as shown by an increase in deposition of mineralized cementum-like tissue in an in vivo transplantation assay. Tooth root dentin modified with mutated functional peptides and transglutaminase did not show enhanced cementogenesis over control, unmodified tooth root dentin. These dramatic differences likely result from the lack of initial targeting/sequestration of the peptide (MB-null peptide) to the dentin surface. Subsequently, without covalent binding (crosslinking), the peptide (TG-null peptide) was not biologically active, resulting in reduced cell attachment.

Our studies demonstrated a significant biological advantage associated with the immobilization of mineralized dentin matrix. Although further studies will be required, it is likely that our approach promotes site-specific delivery/sequestration and increased density of the material to the confined area of interest (mineralized matrix). We speculate that by using this approach, we not only induce and enhance cementogenesis, but we can also prevent overgrowth of induced tissue, sometimes seen as ankylosis (Selvig et al., 2002). Another advantage is the elimination of a carrier or delivery vehicle for the bioactive materials, which, in some situations, may hinder the intimate integration of the newly formed tissue with the tooth root surface (Bosshardt et al., 2005).

Our in vivo results may also help explain why adsorption without subsequent crosslinking of whole adhesive proteins onto tooth root surfaces did not yield consistent enhancement of periodontal regeneration in vivo (Trombelli et al., 1996; Kurtis et al., 2002). Based on our data, it appears that the stable binding of bioactive adhesive molecules is essential. These in vivo experiments show that, if peptides are not covalently bound, there is either no effect or a decrease in the amount of cementum formed. In addition, when peptides are not stably bound, the separation of newly formed cementum from the underlying carrier matrix becomes more evident. It can be suggested that this phenomenon results, in part, from potential leakage of peptide that, in turn, may act as an integrin antagonist (Grzesik and Robey, 1994). As a result, both the cementum formation and the cementum-dentin interface are compromised. Thus, stable binding of the bioactive molecule to the root surface is critical for cementum regeneration to occur.

The cellular and molecular interactions required for cementum formation are not well-elucidated. However, using a modified substrate and committed cementogenic cells, we observed enhanced cementogenesis. Further, no other cell types residing in the periodontium were present in our experimental system, and, for the in vivo experiments, no immune response was present. It is also likely that less-differentiated cementogenic precursor cells and perhaps even the non-committed stem-cell-like cells would possibly respond similarly to the fully committed cementoblastic cells; however, the technology for either the isolation of early cementoblastic precursors/progenitors or cementum-inducing factors is lacking at this time. Thus, it is not possible to design studies addressing these issues experimentally.

In conclusion, this study demonstrates that bioactive peptides can be engineered to target mineralized tissue via mineral-binding poly-glutamic acid residues, and that these can be efficiently bound to tooth root matrices by transglutaminase-catalyzed crosslinking. In principle, this method can be used to target and stably bind any bioactive molecule to a mineralized matrix.


    ACKNOWLEDGMENTS
 
We thank Dr. Edward Macarak for critical review of the manuscript. This investigation was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grants DE-13475 and DE-14600.


    FOOTNOTES
 
A supplemental appendix to this article is published electronically only at http://www.dentalresearch.org.

Received for publication June 21, 2006. Revision received May 6, 2007. Accepted for publication June 7, 2007.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  • Bosshardt DD, Sculean A, Windisch P, Pjetursson BE, Lang NP (2005). Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 40:158–167.[Medline] [Order article via Infotrieve]
  • Folk JE, Finlayson JS (1977). The epsilon-(gamma-glutamyl) lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 31:1–133.[Medline] [Order article via Infotrieve]
  • Fujisawa R, Wada Y, Nodasaka Y, Kuboki Y (1996). Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1292:53–60.[CrossRef][Medline] [Order article via Infotrieve]
  • Ganss B, Kim RH, Sodek J (1999). Bone sialoprotein. Crit Rev Oral Biol Med 10:79–98.[Abstract/Free Full Text]
  • Grzesik WJ, Robey PG (1994). Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 9:487–496.[Medline] [Order article via Infotrieve]
  • Grzesik WJ, Narayanan AS (2002). Cementum and periodontal wound healing and regeneration. Crit Rev Oral Biol Med 13:474–484.[Abstract/Free Full Text]
  • Grzesik WJ, Kuznetsov SA, Uzawa K, Mankani M, Robey PG, Yamauchi M (1998). Normal human cementum-derived cells: isolation, clonal expansion, and in vitro and in vivo characterization. J Bone Miner Res 13:1547–1554.[CrossRef][Medline] [Order article via Infotrieve]
  • Hynes RO (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11–25.[CrossRef][Medline] [Order article via Infotrieve]
  • Ivanovski S, Komaki M, Bartold PM, Narayanan AS (1999). Periodontally-derived cells attach to cementum attachment protein via alpha 5 beta 1 integrin. J Periodontal Res 34:154–159.[CrossRef][Medline] [Order article via Infotrieve]
  • Kurtis B, Balos K, Oygur T (2002). Effect of a collagen membrane enriched with fibronectin on guided tissue regeneration in dogs. Periodontol Clin Investig 24:11–19.
  • Lorand L, Graham RM (2003). Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140–156.[CrossRef][Medline] [Order article via Infotrieve]
  • MacNeil RL, Somerman MJ (1993). Molecular factors regulating development and regeneration of cementum. J Periodontal Res 28:550–559.[CrossRef][Medline] [Order article via Infotrieve]
  • MacNeil RL, Somerman MJ (1999). Development and regeneration of the periodontium: parallels and contrasts. Periodontol 2000 19:8–20.
  • MacNeil RL, Berry J, D’Errico J, Strayhorn C, Piotrowski B, Somerman MJ (1995). Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis. Connect Tissue Res 33:1–7.[Medline] [Order article via Infotrieve]
  • Nakae H, Narayanan AS, Raines E, Page RC (1991). Isolation and characterization of mitogenic factors from cementum. Biochemistry 30:7047–7052.
  • Nanci A (2003). Ten Cate’s oral histology: development, structure, and function. 6th ed. St. Louis, MO: Mosby.
  • Narayanan AS, Bartold PM (1996). Biochemistry of periodontal connective tissues and their regeneration: a current perspective. Connect Tissue Res 34:191–201.[Medline] [Order article via Infotrieve]
  • Pitaru S, McCulloch CA, Narayanan SA (1994). Cellular origins and differentiation control mechanisms during periodontal development and wound healing. J Periodontal Res 29:81–94.[CrossRef][Medline] [Order article via Infotrieve]
  • Saygin NE, Giannobile WV, Somerman MJ (2000). Molecular and cell biology of cementum. Periodontol 2000 24:73–98.
  • Selvig KA, Sorensen RG, Wozney JM, Wikesjö UM (2002). Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol 73:1020–1029.[Medline] [Order article via Infotrieve]
  • Somerman MJ, Shroff B, Agraves WS, Morrison G, Craig AM, Denhardt DT, et al. (1990). Expression of attachment proteins during cementogenesis. J Biol Buccale 18:207–214.[Medline] [Order article via Infotrieve]
  • Trombelli L, Scabbia A, Scapoli C, Calura G (1996). Clinical effect of tetracycline demineralization and fibrin-fibronectin sealing system application on healing response following flap debridement surgery. J Periodontol 67:688–693.[Medline] [Order article via Infotrieve]

Journal of Dental Research, Vol. 86, No. 10, 968-973 (2007)
DOI: 10.1177/154405910708601010


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Song, J.S.
Right arrow Articles by Grzesik, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, J.S.
Right arrow Articles by Grzesik, W.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?